Rating Change
Jefferies analysts initiated coverage on Beta Bionics, Inc. (NASDAQ:BBNX) with a rating of Buy on October 12, 2026.
new coverageNASDAQ:BBNX
Jefferies Initiates Coverage on Beta Bionics, Inc. (BBNX) with Buy
Jefferies analysts initiated coverage on Beta Bionics, Inc. (NASDAQ:BBNX) with a rating of Buy on October 12, 2026.
At publication ·
What changed
Beta Bionics, Inc. (NASDAQ:BBNX) · new coverage
- Firm
- Jefferies
- Rating
- Buy
- Price at event
- $17.86
- Market capitalization
- $1.3B
At a glance
Key takeaways
- Jefferies initiated Buy coverage on Beta Bionics (BBNX) on October 12, 2026, as the healthcare stock trades at $17.86 with a $1.3B market cap.
Market Context
Beta Bionics, Inc. operates in the Healthcare sector. The stock currently trades at $17.86 with a market capitalization of $1.3B. The stock has declined 19.7% over the past 52 weeks.
Analyst coverage from Jefferies provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Beta Bionics, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Beta Bionics, Inc.
Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 12, 2026 | Jefferies | Buy | N/A |
| Sep 24, 2026 | Truist Securities | Buy | N/A |
| Sep 23, 2026 | Wells Fargo | Overweight | N/A |
| Sep 15, 2026 | Truist Securities | Buy | N/A |
| Sep 15, 2026 | B of A Securities | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View BBNX Stock Page
Frequently Asked Questions
What does the Buy rating mean for BBNX?
A rating of Buy from Jefferies reflects the analyst's outlook on Beta Bionics, Inc. (NASDAQ:BBNX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the BBNX forecast page.
